Alexandre Murza

发表

C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action.

Olivier Lesur, Philippe Sarret, O. Lesur, 2015, Journal of medicinal chemistry.

Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Pascal Tétreault, Nicolas Beaudet, Philippe Sarret, 2014, The Journal of clinical investigation.

The signaling signature of the neurotensin type 1 receptor with endogenous ligands

Philippe Sarret, Sandrine Lavenus, R. Leduc, 2017, European journal of pharmacology.